149 related articles for article (PubMed ID: 15150070)
1. Gastric cancer: establishing predictors of biologic behavior with use of population-based data.
Dicken BJ; Saunders LD; Jhangri GS; de Gara C; Cass C; Andrews S; Hamilton SM
Ann Surg Oncol; 2004 Jun; 11(6):629-35. PubMed ID: 15150070
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
3. Biologic predictors of survival in node-negative gastric cancer.
Kooby DA; Suriawinata A; Klimstra DS; Brennan MF; Karpeh MS
Ann Surg; 2003 Jun; 237(6):828-35; discussion 835-7. PubMed ID: 12796579
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
von Rahden BH; Stein HJ; Feith M; Becker K; Siewert JR
J Clin Oncol; 2005 Feb; 23(4):874-9. PubMed ID: 15681533
[TBL] [Abstract][Full Text] [Related]
5. Significant prognostic factors in patients with node-negative gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 1999; 84(4):331-6. PubMed ID: 10667813
[TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
[TBL] [Abstract][Full Text] [Related]
7. Survival predictors in patients with node-negative gastric carcinoma.
Lee CC; Wu CW; Lo SS; Chen JH; Li AF; Hsieh MC; Shen KH; Lui WY
J Gastroenterol Hepatol; 2007 Jul; 22(7):1014-8. PubMed ID: 17608847
[TBL] [Abstract][Full Text] [Related]
8. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract.
Kikuchi E; Horiguchi Y; Nakashima J; Hatakeyama N; Matsumoto M; Nishiyama T; Murai M
J Urol; 2005 Dec; 174(6):2120-3; discussion 2124. PubMed ID: 16280740
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
[TBL] [Abstract][Full Text] [Related]
10. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer.
Kunisaki C; Takahashi M; Nagahori Y; Fukushima T; Makino H; Takagawa R; Kosaka T; Ono HA; Akiyama H; Moriwaki Y; Nakano A
Endoscopy; 2009 Jun; 41(6):498-503. PubMed ID: 19533552
[TBL] [Abstract][Full Text] [Related]
13. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
14. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
15. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
16. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection.
Bentrem D; Wilton A; Mazumdar M; Brennan M; Coit D
Ann Surg Oncol; 2005 May; 12(5):347-53. PubMed ID: 15915368
[TBL] [Abstract][Full Text] [Related]
17. Lymphovascular invasion as a prognostic factor in melanoma.
Egger ME; Gilbert JE; Burton AL; McMasters KM; Callender GG; Quillo AR; Brown RE; St Hill CR; Hagendoorn L; Martin RC; Stromberg AJ; Scoggins CR
Am Surg; 2011 Aug; 77(8):992-7. PubMed ID: 21944512
[TBL] [Abstract][Full Text] [Related]
18. Total number of resected lymph nodes predicts survival in esophageal cancer.
Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H
Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens.
May M; Kaufmann O; Hammermann F; Loy V; Siegsmund M
BJU Int; 2007 Mar; 99(3):539-44. PubMed ID: 17155973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
